Chlamydia Screening in Women – Exploratory Measure Tip Sheet
The percentage of women ages 16 to 24 years old who are identified as sexually active and who had at least one screening for chlamydia during the measurement year.
This is a provisionary measure; there is no payment for 2020. For additional information refer to the 2021 CBI Technical Specifications.
Members who are age 16 to 24 years old, as of the end of the measurement year, and who were determined to be sexually active. Sexual activity is determined by:
- Pregnancy test or diagnosis
- Claim/encounter noting sexual activity
- Contraceptive medication (see CBI Technical Specifications for a full list of medications)
- A pregnancy test during the measurement year and a prescription for isotretinoin (Retinoid) on the date of the pregnancy test or the six days after the pregnancy test.
- A pregnancy test during the measurement year and an x-ray on the date of the pregnancy test, or the six days after the pregnancy test
Chlamydia Screening CPT Codes: 87110, 87270, 87320, 87490, 87491, 87492, 87810
See the full list of chlamydia screening LOINC and SNOMED codes, and Exclusion codes in the CBI Technical Specifications.
Data for this measure will be collected using laboratory data, provider data submissions via the Data Submission Tool on the Provider Portal, and claims.
- Run a report from your Electronic Health Record system
- Manually compile patient data
This measure allows providers to submit Chlamydia screening test results from their EMR/EHR system or paper records to the Alliance at the end of the measurement year by uploading data files to the Data Submission Tool on the Provider Portal. The files are required to be submitted as a CSV file to be accepted. A Data Submission Tool Guide is available on the Provider Portal to provide you with step-by-step instructions.
- Establish routine clinic flow processes for routine screenings.
- Screen if member mentions a new sexual partner.
- Discuss sexual activity and remind members of safe sex practices.
- Consider the community you serve and consult the local health department to identify groups that are at increased risk in your area.
- Establish a recall system using the provider portal quality reports.
- Have a written policy and protocol.
- When screening for STIs, the American Academy of Pediatrics notes special considerations for:
- HIV Screening: Should be performed for everyone ages 13-64
- Screening Adolescents and young adults <25 years: Annual chlamydia and gonorrhea screenings should be performed for women <25 years of age and older women at risk. Syphilis, HIV, chlamydia, and Hepatitis B screenings should be given to all pregnant women, and gonorrhea screening for pregnant women at risk.
- Men Who Have Sex With Men (MSM): These men have higher rates of STIs, such as HIV and syphilis and should be tested for these as well as chlamydia and gonorrhea.
- Refer to the CDC’s A guide to Taking a Sexual History for a sample of discussion points and questions that may be asked.
- Refer to CDC Recommendations for Providing Quality Sexually Transmitted Diseases Clinical Services, 2020 for up to date clinical guidelines